SG
ADAP

StoneX Group’s Adaptimmune Therapeutics ADAP Stock Holding History

StoneX Group’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,431
Closed -$16.7K – 443
2022
Q4 		$16.7K Buy
+11,431
New +$16.7K ﹤0.01% 434